Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2017

01-12-2017 | Case Report

Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE)

Authors: Tatsunori Satoh, Masataka Kikuyama, Shinya Kawaguchi, Hideyuki Kanemoto, Hiroyuki Muro, Keiji Hanada

Published in: Clinical Journal of Gastroenterology | Issue 6/2017

Login to get access

Abstract

A 59-year-old woman was admitted for acute pancreatitis. Abdominal computed tomography and magnetic resonance imaging revealed a swollen pancreatic parenchyma with dilatation of the main pancreatic duct (MPD) of the pancreas tail, which was separated from the normal pancreas body side by a locally atrophic part of the pancreas. Magnetic resonance cholangiopancreatography showed MPD stricture in the pancreas tail with dilatation of the upstream MPD. Endoscopic ultrasonography revealed that the MPD stricture of the pancreas tail was surrounded by a blurred and hypoechoic area. Endoscopic retrograde cholangiopancreatography was performed for serial pancreatic-juice aspiration cytologic examination (SPACE). The result indicated adenocarcinoma. Distal pancreatectomy was performed, and the histopathological examination showed high-grade PanIN (carcinoma in situ of the pancreatic duct) of the pancreas tail with atrophy and fibrosis of the pancreatic parenchyma, and local fat replacement adjacent to the lesion. The final histopathological diagnosis was carcinoma in situ of the pancreatic duct of the pancreas tail. Acute pancreatitis and local fatty change of the pancreatic parenchyma with MPD stricture are important clinical manifestations of pancreatic carcinoma in situ (PCIS) and performing SPACE in cases of MPD stricture without a recognizable mass is preferable for a diagnosis of PCIS.
Literature
1.
go back to reference Egawa S, Toma H, Ohigashi H, et al. A digest of pancreatic cancer registry report 2007. J Jpn Pancreas Soc. 2008;23:105–23.CrossRef Egawa S, Toma H, Ohigashi H, et al. A digest of pancreatic cancer registry report 2007. J Jpn Pancreas Soc. 2008;23:105–23.CrossRef
2.
go back to reference Yoon SH, Lee JM, Cho JY, et al. Small (20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259:442–52.CrossRefPubMed Yoon SH, Lee JM, Cho JY, et al. Small (20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259:442–52.CrossRefPubMed
3.
go back to reference Yasuda I, Iwashita T, Doi S, et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc. 2011;23:22–5.CrossRefPubMed Yasuda I, Iwashita T, Doi S, et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc. 2011;23:22–5.CrossRefPubMed
4.
go back to reference Helmstaedter L, Riemann JF. Pancreatic cancer−EUS and early diagnosis. Langenbecks Arch Surg. 2008;393:923–7.CrossRefPubMed Helmstaedter L, Riemann JF. Pancreatic cancer−EUS and early diagnosis. Langenbecks Arch Surg. 2008;393:923–7.CrossRefPubMed
5.
go back to reference Maehira H, Sugiura T, Kanemoto H, et al. A case of carcinoma in situ of the pancreas with a surrounding fibrotic region. J Jpn Pancreas Soc. 2014;6:919–25.CrossRef Maehira H, Sugiura T, Kanemoto H, et al. A case of carcinoma in situ of the pancreas with a surrounding fibrotic region. J Jpn Pancreas Soc. 2014;6:919–25.CrossRef
6.
go back to reference Mizutani Y, Otuka H, Morishima H, et al. A case of carcinoma in situ of the pancreas. J Jpn Pancreas Soc. 2013;6:785–91.CrossRef Mizutani Y, Otuka H, Morishima H, et al. A case of carcinoma in situ of the pancreas. J Jpn Pancreas Soc. 2013;6:785–91.CrossRef
7.
go back to reference Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas. 2012;41:523–9.CrossRefPubMed Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas. 2012;41:523–9.CrossRefPubMed
8.
go back to reference Ryu S, Motidome N, Fujino M, et al. Early detection of pancreatic cancer or malignant intraductal papillary mucinous neoplasms of the pancreas in the acute pancreatitis patients. J Biliary Tract Pancreas. 2014;35:1207–11. Ryu S, Motidome N, Fujino M, et al. Early detection of pancreatic cancer or malignant intraductal papillary mucinous neoplasms of the pancreas in the acute pancreatitis patients. J Biliary Tract Pancreas. 2014;35:1207–11.
9.
go back to reference Uematsu T, Kubota H, Suzuki H, et al. Carcinoma in situ of the pancreas presenting with acute pancreatitis−report of a case. J Jpn Surg Assoc. 2002;7:1799–803.CrossRef Uematsu T, Kubota H, Suzuki H, et al. Carcinoma in situ of the pancreas presenting with acute pancreatitis−report of a case. J Jpn Surg Assoc. 2002;7:1799–803.CrossRef
10.
go back to reference Kimura U, Kikuyama M, Kodama Y. Acute pancreatitis as a possible indicator of pancreatic cancer: the importance of mass detection. Intern Med. 2015;54:2109–14.CrossRefPubMed Kimura U, Kikuyama M, Kodama Y. Acute pancreatitis as a possible indicator of pancreatic cancer: the importance of mass detection. Intern Med. 2015;54:2109–14.CrossRefPubMed
11.
go back to reference Ito T, Usui M, Iizawa Y, et al. A case of carcinoma in situ of pancreas detected by acute pancreatitis and atrophy of pancreas body. Ther Res Hepato-Biliary-Pancreat Dis. 2016;14:56–62. Ito T, Usui M, Iizawa Y, et al. A case of carcinoma in situ of pancreas detected by acute pancreatitis and atrophy of pancreas body. Ther Res Hepato-Biliary-Pancreat Dis. 2016;14:56–62.
12.
go back to reference Yuge R, Hanada K, Iiboshi T, et al. A case of ductal carcinoma in situ of the pancreas initially suggested by the slightly dilatation of the main pancreatic duct. Hepato-Biliary-Pancreat Imaging. 2012;14:72–7. Yuge R, Hanada K, Iiboshi T, et al. A case of ductal carcinoma in situ of the pancreas initially suggested by the slightly dilatation of the main pancreatic duct. Hepato-Biliary-Pancreat Imaging. 2012;14:72–7.
13.
go back to reference Imaizumi T, Hatori T, Nakasako T, et al. A resected case of carcinoma in situ of the pancreatic body diagnosed preoperatively as invasive ductal adenocarcinoma. J Biliary Tract Pancreas. 1996;17:1083–7. Imaizumi T, Hatori T, Nakasako T, et al. A resected case of carcinoma in situ of the pancreatic body diagnosed preoperatively as invasive ductal adenocarcinoma. J Biliary Tract Pancreas. 1996;17:1083–7.
14.
go back to reference Detlefsen S, Sipos B, Feyerabend B, et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch. 2005;447:800–5.CrossRefPubMed Detlefsen S, Sipos B, Feyerabend B, et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch. 2005;447:800–5.CrossRefPubMed
15.
go back to reference Kiukuyama M, Hanada K, Ueki T. Pancreatic carcinoma in situ presenting prominent fatty change of the pancreatic body on CT: experiences from 3 cases. J Jpn Pancreas Soc. 2015;30:626–32 (in Japanese).CrossRef Kiukuyama M, Hanada K, Ueki T. Pancreatic carcinoma in situ presenting prominent fatty change of the pancreatic body on CT: experiences from 3 cases. J Jpn Pancreas Soc. 2015;30:626–32 (in Japanese).CrossRef
17.
go back to reference Kubota N, Terauchi Y, Miki H, et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597–609.CrossRefPubMed Kubota N, Terauchi Y, Miki H, et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597–609.CrossRefPubMed
18.
go back to reference Kruse ML, Hopf-Jensen S, Timke C, et al. Differentiation potential of pancreatic fibroblastoid cells/stellate cells: effects of peroxisome proliferator-activated receptor gamma ligands. Int J Cell Biol. 2011;2011:816791.CrossRefPubMedPubMedCentral Kruse ML, Hopf-Jensen S, Timke C, et al. Differentiation potential of pancreatic fibroblastoid cells/stellate cells: effects of peroxisome proliferator-activated receptor gamma ligands. Int J Cell Biol. 2011;2011:816791.CrossRefPubMedPubMedCentral
19.
go back to reference Rebours V, Gaujoux S, d’Assignies G, et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanlN). Clin Cancer Res. 2015;21:3522–8.CrossRefPubMed Rebours V, Gaujoux S, d’Assignies G, et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanlN). Clin Cancer Res. 2015;21:3522–8.CrossRefPubMed
Metadata
Title
Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE)
Authors
Tatsunori Satoh
Masataka Kikuyama
Shinya Kawaguchi
Hideyuki Kanemoto
Hiroyuki Muro
Keiji Hanada
Publication date
01-12-2017
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 6/2017
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0776-6

Other articles of this Issue 6/2017

Clinical Journal of Gastroenterology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine